Utility of dynamic contrast enhancement for clinically significant prostate cancer detection

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection

Abstract Objective This study aimed to evaluate the association of dynamic contrast enhancement (DCE) with clinically significant prostate cancer (csPCa, Gleason Grade Group ≥2) and compare biparametric magnetic resonance imaging (bpMRI) and multiparametric MRI (mpMRI) nomograms. Subjects/patients a...

Full description

Saved in:
Bibliographic Details
Main Authors: Eric V. Li, Sai K. Kumar, Jonathan A. Aguiar, Mohammad R. Siddiqui, Clayton Neill, Zequn Sun, Edward M. Schaeffer, Anugayathri Jawahar, Ashley E. Ross, Hiten D. Patel
Format: Article
Language:English
Published: Wiley 2024-09-01
Series:BJUI Compass
Subjects:
diagnosis
dynamic contrast enhancement
nomogram
prostate cancer
prostate MRI
risk stratification
Online Access:https://doi.org/10.1002/bco2.415
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/bco2.415

Similar Items